C12Y 207/07041
Phosphatidate cytidylyltransferase , i.e. cdp-diacylglycerol synthase
Official title: Phosphatidate cytidylyltransferase (2.7.7.41), i.e. CDP-diacylglycerol synthase
C12Y207/07041 (Phosphatidate cytidylyltransferase , i.e. cdp-diacylglycerol synthase) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 4
- Assignees
- 3
- Inventors
- 4
- Latest grant
- 7 Jan 2003
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Treatment of cancers having a drug-resistant mesenchymal cell state7 May 2026US 2026/0125683 A1Dana-Farber Cancer Institute, Inc.
- Mammalian CDP-diacylglycerol synthase21 Jul 2005US 2005/0158797 A1Cell Therapeutics, Inc.
- Mammalian CDP-diacylglycerol synthase12 May 2005US 2005/0100949 A1Cell Therapeutics, Inc.
- Mammalian CDP-diacylglycerol synthase14 Nov 2002US 2002/0168747 A1Cell Therapeutics, Inc.
Most cited
By later US patents